Mrs Karen Smay Fry, CCC-SLP | |
1001 S George St, York, PA 17403-3676 | |
(717) 851-2601 | |
(717) 851-4618 |
Full Name | Mrs Karen Smay Fry |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 1001 S George St, York, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003045162 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | SL002070L (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Karen Smay Fry, CCC-SLP 2010 Parkview Dr, Red Lion, PA 17356-9690 Ph: (717) 244-7228 | Mrs Karen Smay Fry, CCC-SLP 1001 S George St, York, PA 17403-3676 Ph: (717) 851-2601 |
News Archive
Ischaemic heart disease, characterised by reduced blood flow to the heart, is Australia's and the world's leading cause of death.
A bill that could result in the shuttering of up to four of Louisiana's five abortion clinics overwhelmingly received full passage from the Louisiana Legislature Wednesday (May 21), and Gov. Bobby Jindal has indicated he will sign it into law. The legislation is, in part, based on a similar measure passed in Texas last year and led to the closing of several abortion clinics in that state. In its last legislative hurdle, the House concurred an amendment on Wednesday (May 21) that was added to the bill on the Senate side (Lane, 5/22).
A team of scientists from Boston University School of Medicine (BUSM) have identified a novel compound that inhibits viruses from replicating. The findings, which are published online in the Journal of Virology, could lead to the development of highly targeted compounds to block the replication of poxviruses, such as the emerging infectious disease Monkeypox.
Increased uptake of recombinant therapies and prophylactic use, coupled with improved diagnosis of haemophilia, is expected to drive the associated therapeutics market. Recombinant therapies are likely to command a premium price and fuel growth in developed markets, while heightened access to treatment and larger patient volumes due to more funding for critical care are anticipated to contribute to demand in emerging markets.
› Verified 1 days ago
Sandra Lynn Harberger, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1800 E Market St Ste B, York, PA 17402 Phone: 717-364-7778 Fax: 717-382-0196 | |
Marci Jo Merlina, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1802 Folkemer Cir, York, PA 17404 Phone: 717-767-0580 | |
Ms. Margaret L. Whitehead-bien, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2215 E Market St, York, PA 17402 Phone: 717-751-2758 | |
Rachael Franklin, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3995 E Market St, York, PA 17402 Phone: 717-757-1227 | |
Mrs. Sarah Fee Peters, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1500 Memory Lane Ext, York, PA 17402 Phone: 717-757-5433 | |
Miwon Susan Trone, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 25 Monument Rd Ste 175, York, PA 17403 Phone: 717-479-0604 |